VPHIF (Valeo Pharma) Net Margin %: -65.01% (As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Net Margin %?

Valeo Pharma VPHIF -99.00% 12 Net Margin % is -65.01% as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Net margin is calculated as Net Income divided by its Revenue. Valeo Pharma's Net Income for the three months ended in Jul. 2024 was $-5.97 Mil. Valeo Pharma's Revenue for the three months ended in Jul. 2024 was $9.19 Mil. Therefore, Valeo Pharma's net margin for the quarter that ended in Jul. 2024 was -65.01%.

The historical rank and industry rank for Valeo Pharma's Net Margin % or its related term are showing as below:


VPHIF's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

Valeo Pharma  (OTCPK:VPHIF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Valeo Pharma Net Margin % Related Terms

Valeo Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Net Margin % Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Net Margin %
Get a 7-Day Free Trial -54.96 -63.74 -104.99 -92.80 -51.58

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.46 -70.52 -50.76 -55.28 -65.01

VPHIF vs ZTS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeo Pharma Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Net Margin % falls into.


VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Valeo Pharma's Net Margin for the fiscal year that ended in Oct. 2023 is calculated as

Net Margin=Net Income (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-20.28/39.316
=-51.58 %

Valeo Pharma's Net Margin for the quarter that ended in Jul. 2024 is calculated as

Net Margin=Net Income (Q: Jul. 2024 )/Revenue (Q: Jul. 2024 )
=-5.973/9.188
=-65.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -65.01% mean?
Valeo Pharma (VPHIF) has a Net Margin % of -65.01% as of Jul. 2024. Net margin is the ratio of total net income to net sales. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's Net Margin % too high?
Valeo Pharma's current Net Margin % is -65.01%. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Net Margin % compare to ZTS?
Valeo Pharma's Net Margin % of -65.01% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Valeo Pharma and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valeo Pharma's current Net Margin % is -65.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Net Margin % of -65.01%. The current Net Margin % is -65.01%. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Net Margin % is -65.01% as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price